General Practice · Pascagoula, MS
NPI
1790735652
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2809 Denny Ave
Pascagoula, MS, 39581
Phone (228) 809-5510
Groups this clinician bills Medicare through
Medicare paid, 2024
$411K
7,554 services
Medicare patients, 2024
831
Average age 75
Drug cost, 2024
$2.4M
16,785 prescriptions
Company payments, 2025
$1,882
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William D McClendon Jr. was code 99214 (office e&m - established), 1,841 times for 745 patients. In total William D McClendon Jr. billed 7,554 services in 67 codes, and Medicare paid $411K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,841 | 745 | $79.09 | $146K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 548 | 548 | $16.59 | $9,090 |
| 99497 Care Management/Coordination | Office | 542 | 540 | $73.43 | $40K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 542 | 542 | $16.59 | $8,990 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 537 | 537 | $117.15 | $63K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 503 | 503 | $23.13 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 345 | 282 | $11.17 | $3,853 |
| 36415 Venipuncture Blood Collection | Office | 277 | 210 | $8.62 | $2,388 |
| G0008 Administration of influenza virus vaccine | Office | 241 | 237 | $29.46 | $7,100 |
| 90662 Vaccine Product | Office | 229 | 228 | $76.44 | $18K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 180 | 75 | $44.39 | $7,990 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 168 | 33 | $0.75 | $126 |
| 90480 Vaccine Administration | Office | 120 | 111 | $39.29 | $4,715 |
| 80305 Drug Tests | Office | 117 | 70 | $12.35 | $1,445 |
| 96372 Injection Administration | Office | 117 | 33 | $9.87 | $1,154 |
By year: 2022 $552K for 10,472 services; 2023 $541K for 13,577 services; 2024 $411K for 7,554 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 277 | 210 | $8.62 | $2,388 |
| 80305 Drug Tests | 117 | 70 | $12.35 | $1,445 |
| 81002 Clinical Chemistry | 66 | 55 | $3.41 | $225 |
| 83036 Blood Count | 26 | 21 | $9.52 | $248 |
| 87631 Infectious Agent Detection by DNA/RNA | 15 | 15 | $139.78 | $2,097 |
| 87804 Immunoassay | 15 | 13 | $16.22 | $243 |
| 87811 Immunoassay | 13 | 13 | $40.55 | $527 |
Medicare prescription drug claims, 2024
In 2024, the drug William D McClendon Jr. prescribed most often to Medicare patients was Rosuvastatin Calcium, with 672 prescriptions and refills. In total William D McClendon Jr. wrote 16,785 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 672 | 1,850 | 223 | $7,301 |
| Levothyroxine Sodium Generic | 539 | 1,446 | 170 | $4,518 |
| Amlodipine Besylate Generic | 501 | 1,361 | 170 | $3,097 |
| Atorvastatin Calcium Generic | 470 | 1,284 | 143 | $3,690 |
| Gabapentin Generic | 451 | 886 | 141 | $6,086 |
| Omeprazole Generic | 438 | 1,157 | 149 | $4,636 |
| Metformin Hcl Generic | 381 | 1,010 | 114 | $1,994 |
| Valsartan Generic | 360 | 1,000 | 115 | $9,357 |
| Trazodone Hcl Generic | 306 | 713 | 94 | $3,306 |
| Metoprolol Succinate Generic | 304 | 777 | 98 | $3,119 |
| Jardiance Empagliflozin | 303 | 688 | 97 | $391K |
| Lisinopril Generic | 287 | 774 | 92 | $2,042 |
| Furosemide Generic | 275 | 640 | 98 | $1,126 |
| Sertraline Hcl Generic | 254 | 586 | 75 | $1,998 |
| Losartan Potassium Generic | 248 | 667 | 88 | $1,899 |
Brand drugs: 2,576 claims; generic drugs: 14,154 claims; opioid claims: 603.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William D McClendon Jr. $1,882 ($1,882 in general payments such as food, travel and fees) from 23 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $220.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $220 |
| Novo Nordisk Inc NVO | 11 | $159 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $153 |
| Amgen Inc. AMGN | 10 | $148 |
| Sumitomo Pharma America, Inc. 4506.T | 8 | $146 |
| Janssen Pharmaceuticals, Inc JNJ | 6 | $129 |
| Lilly USA, LLC LLY | 8 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $96.7 |
| Lundbeck LLC | 4 | $88.14 |
| Pfizer Inc. PFE | 4 | $87.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.